Special Drug Use-results Survey for Long-term Use
| Registry | NCT06758271 |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Enrollment | 250 (Estimated) |
| Sponsor | Kissei Pharmaceutical Co., Ltd. (Industry) |
| Conditions | Microscopic Polyangiitis (MPA), Granulomatosis With Polyangiitis (GPA) |
| Interventions | Avacopan (Drug) |
| Dates | start 2022-07-29, primary completion 2028-05-31 (estimated), completion 2028-05-31 (estimated), first posted 2025-01-03, last updated 2025-01-17 |
| Locations | 1 site in Japan |
Related Papers Related Patents Related Grants Related Experts
All trials for Microscopic Polyangiitis (MPA) All trials for Granulomatosis With Polyangiitis (GPA) All trials of Avacopan
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Avacopan treatmented | Drug: Avacopan |
Sex: All
Inclusion Criteria: * Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
| Facility | City | Country | Status |
|---|---|---|---|
| Research site | Multiple Locations | Japan | Recruiting |